• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国和香港人群对人源和禽流感 H2N2 病毒的血清学免疫情况用于大流行风险评估。

Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment.

机构信息

Department of Infectious Diseases, University of Rochester Medical Center, New York.

School of Public Health, The University of Hong Kong.

出版信息

J Infect Dis. 2018 Aug 24;218(7):1054-1060. doi: 10.1093/infdis/jiy291.

DOI:10.1093/infdis/jiy291
PMID:29762672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6107991/
Abstract

BACKGROUND

Influenza A pandemics cause significant mortality and morbidity. H2N2 viruses have caused a prior pandemic, and are circulating in avian reservoirs. The age-related frequency of current population immunity to H2 viruses was evaluated.

METHODS

Hemagglutinin inhibition (HAI) assays against historical human and recent avian influenza A(H2N2) viruses were performed across age groups in Rochester, New York, and Hong Kong, China. The impact of existing cross-reactive HAI immunity on the effective reproduction number was modeled.

RESULTS

One hundred fifty individual sera from Rochester and 295 from Hong Kong were included. Eighty-five percent of patients born in Rochester and Hong Kong before 1968 had HAI titers ≥1:40 against A/Singapore/1/57, and >50% had titers ≥1:40 against A/Berkeley/1/68. The frequency of titers ≥1:40 to avian H2N2 A/mallard/England/727/06 and A/mallard/Netherlands/14/07 in subjects born before 1957 was 62% and 24%, respectively. There were no H2 HAI titers >1:40 in individuals born after 1968. These levels of seroprevalence reduce the initial reproduction number of A/Singapore/1/1957 or A/Berkeley/1/68 by 15%-20%. A basic reproduction number (R0) of the emerging transmissible virus <1.2 predicts a preventable pandemic.

CONCLUSIONS

Population immunity to H2 viruses is insufficient to block epidemic spread of H2 virus. An H2N2 pandemic would have lower impact in those born before 1968.

摘要

背景

甲型流感大流行可导致严重的死亡率和发病率。H2N2 病毒曾引发过一次大流行,目前存在于禽类储库中。本研究评估了当前人群对 H2 病毒的年龄相关免疫频率。

方法

在纽约罗切斯特和中国香港,对各年龄段人群进行了针对历史上的人类和近期的甲型流感 A(H2N2)病毒的血凝抑制(HAI)检测。对现有交叉反应性 HAI 免疫对有效繁殖数的影响进行了建模。

结果

罗切斯特和香港各有 150 份和 295 份个体血清被纳入研究。1968 年以前在罗切斯特和香港出生的 85%的患者对 A/Singapore/1/57 的 HAI 滴度≥1:40,>50%的患者对 A/Berkeley/1/68 的 HAI 滴度≥1:40。1957 年前出生的受试者对 A/mallard/England/727/06 和 A/mallard/Netherlands/14/07 的 H2N2 禽源 HAI 滴度≥1:40 的频率分别为 62%和 24%。1968 年后出生的个体均无 H2 HAI 滴度>1:40。这些血清阳性率水平使 A/Singapore/1/1957 或 A/Berkeley/1/68 的初始繁殖数减少 15%-20%。具有<1.2 的基本繁殖数(R0)的新发可传播病毒可预防大流行。

结论

人群对 H2 病毒的免疫力不足以阻止 H2 病毒的流行传播。1968 年前出生的人群发生 H2N2 大流行的影响较小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a747/6107991/d461c2252c73/jiy29103.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a747/6107991/0800ae495f07/jiy29101.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a747/6107991/3b1249211f42/jiy29102.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a747/6107991/d461c2252c73/jiy29103.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a747/6107991/0800ae495f07/jiy29101.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a747/6107991/3b1249211f42/jiy29102.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a747/6107991/d461c2252c73/jiy29103.jpg

相似文献

1
Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment.美国和香港人群对人源和禽流感 H2N2 病毒的血清学免疫情况用于大流行风险评估。
J Infect Dis. 2018 Aug 24;218(7):1054-1060. doi: 10.1093/infdis/jiy291.
2
H2 influenza viruses: designing vaccines against future H2 pandemics.H2 流感病毒:设计针对未来 H2 大流行的疫苗。
Biochem Soc Trans. 2019 Feb 28;47(1):251-264. doi: 10.1042/BST20180602. Epub 2019 Jan 15.
3
Determining Existing Human Population Immunity as Part of Assessing Influenza Pandemic Risk.评估流感大流行风险的一部分是确定现有人群的免疫情况。
Emerg Infect Dis. 2022 May;28(5):977-985. doi: 10.3201/eid2805.211965.
4
Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.香港人群对甲型 H1N1 流感病毒的血清学免疫和血清学反应。
J Med Virol. 2010 Nov;82(11):1809-15. doi: 10.1002/jmv.21895.
5
Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic.大流行悖论:H2N2 大流行流感早期感染增加了 2009 年 H1N1 大流行期间的死亡易感性。
mBio. 2018 Jan 16;9(1):e02091-17. doi: 10.1128/mBio.02091-17.
6
Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.健康志愿者体内针对大流行的A/加利福尼亚/07/2009(H1N1)流感病毒的血清型特异性或交叉反应性神经氨酸酶抑制抗体。
BMC Res Notes. 2015 Apr 10;8:136. doi: 10.1186/s13104-015-1086-z.
7
The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses.人类 A/H2N2 流感病毒抗原漂移的分子基础。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.01907-18. Print 2019 Apr 15.
8
Risk assessment of H2N2 influenza viruses from the avian reservoir.从禽类宿主中评估 H2N2 流感病毒的风险。
J Virol. 2014 Jan;88(2):1175-88. doi: 10.1128/JVI.02526-13. Epub 2013 Nov 13.
9
A(H2N2) and A(H3N2) influenza pandemics elicited durable cross-reactive and protective antibodies against avian N2 neuraminidases.A(H2N2) 和 A(H3N2) 流感大流行引发了针对禽 N2 神经氨酸酶的持久交叉反应性和保护性抗体。
Nat Commun. 2024 Jul 3;15(1):5593. doi: 10.1038/s41467-024-49884-9.
10
Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.经计算优化的广谱反应性 H2 HA 流感疫苗可诱导广谱交叉反应性抗体,并保护小鼠免受病毒挑战。
J Virol. 2020 Dec 22;95(2). doi: 10.1128/JVI.01526-20.

引用本文的文献

1
Dual receptor-binding, infectivity, and transmissibility of an emerging H2N2 low pathogenicity avian influenza virus.新兴 H2N2 低致病性禽流感病毒的双重受体结合、感染性和传染性。
Nat Commun. 2024 Nov 19;15(1):10012. doi: 10.1038/s41467-024-54374-z.
2
Continued adaptation of A/H2N2 viruses during pandemic circulation in humans.人类大流行期间 A/H2N2 病毒的持续适应。
J Gen Virol. 2023 Aug;104(8). doi: 10.1099/jgv.0.001881.
3
Varying Viral Replication and Disease Profiles of H2N2 Influenza in Ferrets Is Associated with Virus Isolate and Inoculation Route.

本文引用的文献

1
Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1.季节性甲型H3N2流感与2009年大流行的甲型H1N1流感相比的相对发病率和个体水平严重程度。
BMC Infect Dis. 2017 May 11;17(1):337. doi: 10.1186/s12879-017-2432-7.
2
Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.抗流感病毒神经氨酸酶抗体:保护作用的独立相关因素。
J Infect Dis. 2015 Oct 15;212(8):1191-9. doi: 10.1093/infdis/jiv195. Epub 2015 Apr 8.
3
Adaptation of pandemic H2N2 influenza A viruses in humans.
不同的 H2N2 流感病毒在雪貂体内的复制和疾病特征与病毒分离株和接种途径有关。
J Virol. 2022 Jul 27;96(14):e0073222. doi: 10.1128/jvi.00732-22. Epub 2022 Jul 11.
4
Adenoviral-Vectored Centralized Consensus Hemagglutinin Vaccine Provides Broad Protection against H2 Influenza a Virus.腺病毒载体集中式共识血凝素疫苗对H2甲型流感病毒提供广泛保护。
Vaccines (Basel). 2022 Jun 10;10(6):926. doi: 10.3390/vaccines10060926.
5
The Continued Threat of Influenza A Viruses.甲型流感病毒的持续威胁。
Viruses. 2022 Apr 24;14(5):883. doi: 10.3390/v14050883.
6
Determining Existing Human Population Immunity as Part of Assessing Influenza Pandemic Risk.评估流感大流行风险的一部分是确定现有人群的免疫情况。
Emerg Infect Dis. 2022 May;28(5):977-985. doi: 10.3201/eid2805.211965.
7
Serologic Evidence of Occupational Exposure to Avian Influenza Viruses at the Wildfowl/Poultry/Human Interface.野生禽类/家禽/人类界面处职业性接触禽流感病毒的血清学证据。
Microorganisms. 2021 Oct 15;9(10):2153. doi: 10.3390/microorganisms9102153.
8
Seasonal influenza vaccination does not effectively expand H2 cross-reactive antibodies in humans.季节性流感疫苗接种不能有效地在人体中扩增 H2 交叉反应性抗体。
Vaccine. 2021 Jul 5;39(30):4173-4183. doi: 10.1016/j.vaccine.2021.05.064. Epub 2021 Jun 12.
9
Systemic and respiratory T-cells induced by seasonal H1N1 influenza protect against pandemic H2N2 in ferrets.季节性H1N1流感诱导产生的全身和呼吸道T细胞可保护雪貂免受大流行H2N2流感的侵害。
Commun Biol. 2020 Oct 9;3(1):564. doi: 10.1038/s42003-020-01278-5.
10
Comparison of COVID-19 Health Risks With Other Viral Occupational Hazards.比较 COVID-19 健康风险与其他病毒性职业危害。
Int J Health Serv. 2021 Jan;51(1):37-49. doi: 10.1177/0020731420946590. Epub 2020 Aug 9.
甲型H2N2大流行性流感病毒在人体内的适应性
J Virol. 2015 Feb;89(4):2442-7. doi: 10.1128/JVI.02590-14. Epub 2014 Dec 10.
4
Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature.季节性、大流行和动物源流感的繁殖数估计:文献系统评价。
BMC Infect Dis. 2014 Sep 4;14:480. doi: 10.1186/1471-2334-14-480.
5
Pandemic preparedness and the Influenza Risk Assessment Tool (IRAT).大流行防范与流感风险评估工具(IRAT)。
Curr Top Microbiol Immunol. 2014;385:119-36. doi: 10.1007/82_2014_419.
6
Inferring influenza infection attack rate from seroprevalence data.从血清流行率数据推断流感感染发病率。
PLoS Pathog. 2014 Apr 3;10(4):e1004054. doi: 10.1371/journal.ppat.1004054. eCollection 2014 Apr.
7
Risk assessment of H2N2 influenza viruses from the avian reservoir.从禽类宿主中评估 H2N2 流感病毒的风险。
J Virol. 2014 Jan;88(2):1175-88. doi: 10.1128/JVI.02526-13. Epub 2013 Nov 13.
8
Cellular immune correlates of protection against symptomatic pandemic influenza.细胞免疫与保护人体免受大流行性流感症状感染的相关性。
Nat Med. 2013 Oct;19(10):1305-12. doi: 10.1038/nm.3350. Epub 2013 Sep 22.
9
Host versus flu: antibodies win a round?宿主对抗流感:抗体赢得一局?
Nat Struct Mol Biol. 2013 Mar;20(3):245-6. doi: 10.1038/nsmb.2524.
10
Correlates of protection to influenza virus, where do we go from here?流感病毒保护相关因素,我们的路在何方?
Hum Vaccin Immunother. 2013 Feb;9(2):405-8. doi: 10.4161/hv.22908. Epub 2013 Jan 4.